- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 15.01M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $35.15M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $39.6M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $59.06M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $63.47M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $105.99M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $112.86M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $66.16M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $72.9M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $93M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $100M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 11.88M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $0 |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $5.24M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$105.59M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$102.11M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.44 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.44 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $3.96M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $4.68M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$4.46M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$2.95M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $13.24M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $37.51M |